Runcaciguat (BAY-1101042 BAY1101042) is a novel, potent and orally bioactive stimulator/activator of soluble guanylate cyclase. The novel sGC activator runcaciguat targets the oxidized and heme-free form of sGC, restoring cGMP production under oxidative stress. It has the potential to be used as an efficient treatment approach for CKD and associated CV diseases.

纯度：≥98%

CAS：1402936-61-1